HAG
TMDX icon

HighPoint Advisor Group’s Transmedics TMDX Stock Holding History

HighPoint Advisor Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,646
Closed -$362K – 708
2026
Q1 		$362K Sell
3,646
-2,092
-36% -$273K 0.02% 492
2025
Q4 		$698K Buy
5,738
+2,871
+100% +$360K 0.02% 575
2025
Q3 		$322K Buy
2,867
+1,075
+60% +$126K 0.02% 512
2025
Q2 		$240K Buy
+1,792
New +$197K 0.01% 595
2024
Q4 		– Sell
-9,186
Closed -$757K – 737
2024
Q3 		$757K Buy
9,186
+881
+11% +$136K 0.04% 280
2024
Q2 		$1.15M Sell
8,305
-380
-4% -$45.6K 0.07% 207
2024
Q1 		$1.15M Buy
8,685
+1,045
+14% +$86.1K 0.08% 193
2023
Q4 		$543K Buy
+7,640
New +$461K 0.04% 338

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HighPoint Advisor Group's TMDX Position: Q2 2026 in Review

HighPoint Advisor Group sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,646 shares — an estimated $362K sold.

HighPoint Advisor Group first reported a position in TMDX in Q4 2023 and held it in 8 quarters. The position peaked at $1.15M in Q2 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • HighPoint Advisor Group reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 3,646 Transmedics shares in Q2 2026, an estimated $362K.
  • HighPoint Advisor Group first reported a position in Transmedics in Q4 2023 and held it in 8 quarters.
  • HighPoint Advisor Group's Transmedics position peaked at $1.15M in Q2 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.